Levantex Laboratories Private Limited
About Levantex Laboratories Private Limited
Data last updated:
Levantex Laboratories Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 October 2008.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2008PTC184235.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Chanpreet Singh and Sanjay Dewan.
Its last annual general meeting (AGM) was held on 28 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at S – 78 Greater Kailash Part – I, New Delhi, Delhi, India – 110048.
Company details
Contact details
Levantex Laboratories Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressS – 78 Greater Kailash Part – I, New Delhi, Delhi, India – 110048
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Levantex Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Levantex Laboratories Private Limited
FY 2020 filings availableLevantex Laboratories Private Limited reported revenue of ₹3,125 (down 83% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 31% over five years, including a 83% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Levantex Laboratories Private Limited, buy the company report.
Board of directors of Levantex Laboratories Private Limited
Levantex Laboratories has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chanpreet Singh Also directs: Monk Fitness LLP | Director | 25 Mar 2015 | 11 Years 7 Months | As last reported |
| Sanjay Dewan | Director | 25 Mar 2015 | 11 Years 7 Months | As last reported |
Peer comparison
Levantex Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Baijnath Distributors Private Limited | ₹3,686 (FY 2025) | -84.0% | Patna, Bihar, India | |||
| Medimerz Pharma Private Limited | ₹3,503 (FY 2024) | -99.0% | Hyderabad, Telangana, India | |||
| Anv Pharmacy Private Limited | ₹3,405 (FY 2025) | 5.0% | Gurgaon, Haryana, India | |||
| J4serv Private Limited | ₹3,335 (FY 2024) | -100.0% | Delhi, India | |||
| Vipul Drugs Private Limited | ₹3,130 (FY 2024) | 1336.0% | Mumbai, Maharashtra, India | |||
| Levantex Laboratories Private Limitedthis company | ₹3,125 (FY 2020) | -83.0% | New Delhi, Delhi, India | |||
| Fyodor Trade Plus Private Limited | ₹3,000 (FY 2025) | -91.0% | Pune, Maharashtra, India | |||
| El-Life Medi Pharma Limited | ₹3,000 (FY 2019) | -100.0% | Jaipur, Rajasthan, India | |||
| Genxbio Health Sciences Private Limited | ₹2,906 (FY 2025) | -87.0% | Delhi, India | |||
| German Health Care Private Limited | ₹2,872 (FY 2024) | 884.0% | Indore, Madhya Pradesh, India | |||
| Be Pellets Limited | ₹2,724 (FY 2025) | -100.0% | Chandigarh, India |
To see the full peer comparison of Levantex Laboratories Private Limited, buy the company report.
Auditor
Levantex Laboratories Private Limited is audited by SUNIL DHAWAN & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUNIL DHAWAN & ASSOCIATES | FY 2017 | 006645N |
Shareholding
The shareholding of Levantex Laboratories Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Levantex Laboratories Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Levantex Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Levantex Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Levantex Laboratories Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Levantex Laboratories Private Limited has 9 board changes on record since 2014: 2 appointments and 7 cessations. The latest: Chanpreet Singh ceased to be Additional Director on 30 Sep 2015.
Frequently asked questions
Levantex Laboratories has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Levantex Laboratories was a private limited company based in New Delhi, Delhi, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 October 2008 and is registered under CIN U74900DL2008PTC184235. The company has been struck off by the Registrar of Companies and is no longer operational.
Levantex Laboratories had 2 directors:
- Chanpreet Singh - Director
- Sanjay Dewan - Director
The CIN (Corporate Identification Number) of Levantex Laboratories is U74900DL2008PTC184235. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Levantex Laboratories is at S – 78 Greater Kailash Part – I, New Delhi, Delhi, India – 110048.
Levantex Laboratories was incorporated on 14 October 2008. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Levantex Laboratories on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 28 December 2020. Year-wise statements from 2015 are in the company report.
Levantex Laboratories operated in the pharma industry, in the pharmaceutical retailers and distributors segment. It worked in this industry before it was struck off.
The peers of Levantex Laboratories by revenue are Baijnath Distributors Private Limited, Medimerz Pharma Private Limited, Anv Pharmacy Private Limited, J4serv Private Limited, Vipul Drugs Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Chanpreet Singh ceased to be Additional Director on 30 Sep 2015. Sanjay Dewan ceased to be Additional Director on 30 Sep 2015. Chanpreet Singh was appointed as Director on 25 Mar 2015. Levantex Laboratories has 9 board changes on record in total.
The compliance status of Levantex Laboratories is compliant as of 21 July 2026.